2 "COVID-19" clinical trials found.
-
A Phase 2 Study of BIO 300 in Patients with COVID-19
COVID-19 is caused by a virus that triggers inflammation of the lungs. This inflammation may damage the lungs and lead to scarring. This scarring causes ... -
Randomized Double-Blind Placebo-Controlled Phase 2 Trial to Evaluate the Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery after Surgery (ERAS) Protocol in Subjects Undergoing Bowel Resection
Tsumura, USA, Inc. (Tsumura) has begun a study of an investigational drug (also known as the “study drug”) called TU-100 (daikenchuto) as a possible add-on ...